3-5 million severe cases per year, (300,000-600,000 deaths per year)
Prevention: Mass vaccinations (tri/quad-rivalent), anti-viral drugs (oseltamivir/zanamivir), infection control (frequent hand-washing/alcohol-based hand sanitizer/covering mouth/nose during infection)
Creutzfeldt-Jakob Disease (CJD)
Caused by the misfolding of a protein (prion) which causes the breakdown and damage of brain tissue with infected
Only 10% of CJD has been linked to inheritance with the cause currently being unknown, but linked to ingestion of prion material (human or zootonic)
Caused lack of vitamin A in blood/tissue, due to reduced or no consumption of Pro-vitamin A from the diet
Symptoms: Blindness/Increased Infection rate/keratosis internal and external epithelial
Globally prevalent: More common in Sub-Saharan Africa
~251 million affected, ~250,000-500,000 under 5 deaths annually
Prevention: Increased and improved diet, with improved provitamin A compounds (Pepper/Leaf-Green Vegetables)
Obesity
Caused by: Excessive consumption of energy-dense foods, sedentary lifestyle, lack of physical activity
Increased risk of CHD, deep vein thrombosis, infertility, stroke, dementia, depression, reduced mobility, gout and death
Globally prevalent, increased in High Developed Economy Countries
700 million (12% of global population) with 2.8 million dying per year
Prevention: Improved and reduced diet, improved mobility/exercise, surgery
Depression
A mental state which is characterised by low mood, aversion to activity, loss of pleasure or joy
Causes are currently not fully elucidated, but linked to alteration in brain chemistry, stressful life events, drug abuse
Approximately 300 million people (4.4% of global population)
Treatment is currently forms of psychotherapy and psychopharmacology
Disease burden
The impact in which a health issue has on an area
Measured by the financial cost, mortality, and morbidity of the disease states
Can be specific or broad, measuring a single disease in an area, or the overall global effect of the disease
Measured via YPLL (years of potential life lost) and DALY (disability-adjusted life year)
YPLL
A simple estimate of the number of years that a person's life is shortened due to a disease
932,000,000 YPLL were lost globally in 2004 (WHO)
DALY
Like YPLL, but considers years where the patient is also unhealthy during their disease state, measuring the economic and social burden of people who are very sick
1,500,000,000 DALY were lost globally in 2004 (WHO)
Disease burden by category
Premature Birth
Neuropsychiatric
Infectious Disease
Cardiovascular
Cancer
Injuries
Roles of different organisations
Researchers
Health Care
Government
Researchers
Fundamental to gather and analyse the behaviours, symptoms, risk factors, and trends of diseases and infected people, provide support to develop treatments and assess the risks of new diseases
Health Care
Treating individual cases, gathering large-scale datasets, and improving life expectancy and quality
Government
Providing support mechanisms of healthcare and well-being, ensure that policies exist to support framework for pandemic and disease prevention
Non-communicable diseases
Disease which can't be transferred from a diseased individual and non-diseased individual
Examples of non-communicable diseases
Cancer
Atherosclerosis
Diabetes
Infectious diseases
Diseases which are transferable between people
Cardiovascular diseases
Coronary Heart Disease - reduced blood supply to heart muscles
Cerebrovascular Disease - reduced blood supply to the brain
Peripheral Arterial Disease - reduced blood supply to the limbs
Rheumatic Heart Disease - damage to the heart muscles and valves from a fever
Congenital Heart Disease - birth defects which affect development and function of the heart tissue
Deep Vein thrombosis - blood clots in the leg veins, which can dislodge and move to the heart/lungs
Atherosclerosis
Characterised by the development of lesions within the walls of arteries
Begins with macrophage infiltration which absorbs excess cholesterol within the intracellular space
The cholesterol rich macrophage clump together to form a thick debris-filled plaque
The formation of the plaque narrows the blood vessel, which slows the flow oxygen-rich blood to organs and limbs
This reduces the efficiency of organs and limbs as there is a reduced oxygen transfer from the red blood cells into these organs/tissues
Plaques can grow or break off, which can form blood clots, which completely restrict blood flow resulting in CHD/CVD